RPL13 and breast carcinoma: Surprisingly, in our omics data, we also observed down-regulation for RPL13 expression (PRG treatment only) and RPL38 expression (PRG treatment and CSC-KD) in nPR(+) T47D cells (Fig. 8, panel A1), validating their role as intrinsic biomarkers in Luminal-A breast cancers.